Claire specialises in commercial and intellectual property transactions, most notably in the life sciences, technology, media and consumer product sectors.

Claire advises on a wide variety of commercial and IP transactions (the large majority of which are cross-border) and on corporate and investment deals where IP is an important asset.

Before becoming a lawyer, Claire spent a number of years working for Abbott Laboratories’ medical device business. Since being at Bristows, Claire has also spent time seconded to the in-house legal team of a leading global pharmaceutical company. She is also a member of the UK Bio Industry Association’s Intellectual Property Advisory Committee.

Examples of her recent experience include advising:

• pharmaceutical, biotech, medical device and digital health companies on joint ventures, R&D collaborations, strategic partnerships and licensing deals (with commercial and academic partners) to bring novel treatments and devices to market
• leading pharmaceutical companies on acquisitions and disposals of rights in medicinal products and the sale of manufacturing and packaging facilities
• multinational companies on key COVID-19 projects, including collaborations relating to a multijurisdictional clinical trial for a COVID-19 vaccine, and setting up and operating a COVID-19 testing facility
• SMEs and international organisations on development, services, manufacturing, supply and distribution agreements for a wide range of pharmaceutical, industrial and consumer products
• a fast-growing start-up on the IP and commercial arrangements relating to the creation, protection and exploitation of a new children’s character.